Exact Mass: 482.0199

Exact Mass Matches: 482.0199

Found 69 metabolites which its exact mass value is equals to given mass value 482.0199, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Thymidine 5'-triphosphate

{[hydroxy({[hydroxy({[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphoryl]oxy})phosphoryl]oxy}phosphonic acid

C10H17N2O14P3 (481.9893)


Thymidine-5-triphosphate, also known as ttp or deoxythymidine 5-triphosphoric acid, is a member of the class of compounds known as pyrimidine 2-deoxyribonucleoside triphosphates. Pyrimidine 2-deoxyribonucleoside triphosphates are pyrimidine nucleotides with a triphosphate group linked to the ribose moiety lacking a hydroxyl group at position 2. Thymidine-5-triphosphate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). Thymidine-5-triphosphate can be found in a number of food items such as kohlrabi, garden tomato (variety), cardoon, and star anise, which makes thymidine-5-triphosphate a potential biomarker for the consumption of these food products. Thymidine-5-triphosphate exists in all living species, ranging from bacteria to humans. In humans, thymidine-5-triphosphate is involved in the pyrimidine metabolism. Thymidine-5-triphosphate is also involved in few metabolic disorders, which include beta ureidopropionase deficiency, dihydropyrimidinase deficiency, MNGIE (mitochondrial neurogastrointestinal encephalopathy), and UMP synthase deficiency (orotic aciduria). Deoxythymidine triphosphate (dTTP) is one of the four nucleoside triphosphates that are used in the in vivo synthesis of DNA. Unlike the other deoxyribonucleoside triphosphates, thymidine triphosphate does not always contain the "deoxy" prefix in its name. The corresponding ribonucleoside triphosphate is called uridine triphosphate. Thymidine 5-triphosphate, also known as TTP or DTHD5ppp, belongs to the class of organic compounds known as pyrimidine 2-deoxyribonucleoside triphosphates. These are pyrimidine nucleotides with a triphosphate group linked to the ribose moiety lacking a hydroxyl group at position 2. Thymidine 5-triphosphate exists in all living species, ranging from bacteria to humans. Outside of the human body, Thymidine 5-triphosphate has been detected, but not quantified in several different foods, such as elliotts blueberries, mamey sapotes, sesames, alliums, and sweet oranges.

   

3-Phosphocytidine 5-diphosphoramidate

3-Phosphocytidine 5-diphosphoramidate

C9H17N4O13P3 (482.0005)


   

Lentinic acid

2-Amino-4-[(1-carboxy-2-methanesulphonylmethanesulphinylmethanesulphinylmethanesulphinylethyl)-C-hydroxycarbonimidoyl]butanoic acid

C12H22N2O10S4 (482.0157)


Lentinic acid is found in mushrooms. Lentinic acid is isolated from the mushroom Lentinus edodes. Isolated from the mushroom Lentinus edodes. Lentinic acid is found in mushrooms.

   

2,3-(S)-hexahydroxydiphenoyl-D-glucose

2,3-(S)-hexahydroxydiphenoyl-D-glucose

C20H18O14 (482.0697)


   

3,4,5,11,12,13,21,22,23-nonahydroxy-9,14,17-trioxatetracyclo[17.4.0.0(2),.0(1),(1)]tricosa-1(23),2,4,6,19,21-hexaene-8,18-dione

3,4,5,11,12,13,21,22,23-nonahydroxy-9,14,17-trioxatetracyclo[17.4.0.0(2),.0(1),(1)]tricosa-1(23),2,4,6,19,21-hexaene-8,18-dione

C20H18O14 (482.0697)


   

6,7,8,11,12,13,21,22,23-nonahydroxy-2,17,20-trioxatetracyclo[17.3.1.0,.0(1),(1)]tricosa-4,6,8,10,12,14-hexaene-3,16-dione

6,7,8,11,12,13,21,22,23-nonahydroxy-2,17,20-trioxatetracyclo[17.3.1.0,.0(1),(1)]tricosa-4,6,8,10,12,14-hexaene-3,16-dione

C20H18O14 (482.0697)


   

N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

C16H14F3IN2O4 (481.995)


   

[Hydroxy-[[(2R,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate

{[hydroxy({[hydroxy({[3-hydroxy-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy})phosphoryl]oxy})phosphoryl]oxy}phosphonic acid

C10H17N2O14P3 (481.9893)


   
   
   

degalloyl-punicacortein A

degalloyl-punicacortein A

C20H18O14 (482.0697)


   
   

4,6-(S)-HHDP-D-glucose|4,6-O-((S)-4,4,5,5,6,6-hexahydroxydiphenoyl)-D-glucose|4,6-O-<(S)-4,4,5,5,6,6-hexahydroxydiphenoyl>-D-glucose

4,6-(S)-HHDP-D-glucose|4,6-O-((S)-4,4,5,5,6,6-hexahydroxydiphenoyl)-D-glucose|4,6-O-<(S)-4,4,5,5,6,6-hexahydroxydiphenoyl>-D-glucose

C20H18O14 (482.0697)


   

Triumbelletin

Triumbelletin

C27H14O9 (482.0638)


   
   
   

N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide

N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide

C16H14F3IN2O4 (481.995)


   

Thymidine 5-triphosphate

Thymidine 5-triphosphate

C10H17N2O14P3 (481.9893)


   

PD 0325901

N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide

C16H14F3IN2O4 (481.995)


Mirdametinib (PD0325901) is an orally active, selective and non-ATP-competitive MEK inhibitor with an IC50 of 0.33 nM. Mirdametinib exhibits a Kiapp of 1 nM against activated MEK1 and MEK2. Mirdametinib suppresses the expression of p-ERK1/2 and induces apoptosis. Mirdametinib has anti-cancer activity for a broad spectrum of human tumor xenografts[1][2][3].

   

LENTINIC ACID

2-amino-4-[(1-carboxy-2-{[(methanesulfonylmethane)sulfinylmethane]sulfinylmethane}sulfinylethyl)carbamoyl]butanoic acid

C12H22N2O10S4 (482.0157)


   

2-(4-Iodophenyl)-4,5-bis(4-methoxyphenyl)-1H-imidazole

2-(4-Iodophenyl)-4,5-bis(4-methoxyphenyl)-1H-imidazole

C23H19IN2O2 (482.0491)


   

5-((4-BROMO-2-CHLOROPHENYL)AMINO)-4-FLUORO-1-METHYL-N-(2-(VINYLOXY)ETHOXY)-1H-BENZO[D]IMIDAZOLE-6-CARBOXAMIDE

5-((4-BROMO-2-CHLOROPHENYL)AMINO)-4-FLUORO-1-METHYL-N-(2-(VINYLOXY)ETHOXY)-1H-BENZO[D]IMIDAZOLE-6-CARBOXAMIDE

C19H17BrClFN4O3 (482.0157)


   

Ammonium iron(III) sulfate dodecahydrate

Ammonium iron(III) sulfate dodecahydrate

FeH28NO20S2 (481.9995)


   

Ferrous gluconate dihydrate

Ferrous gluconate dihydrate

C12H26FeO16 (482.057)


B - Blood and blood forming organs > B03 - Antianemic preparations > B03A - Iron preparations > B03AA - Iron bivalent, oral preparations D006401 - Hematologic Agents > D006397 - Hematinics

   

BIS(1,5-CYCLOOCTADIENE)DIMETHOXYDIRHODIUM

BIS(1,5-CYCLOOCTADIENE)DIMETHOXYDIRHODIUM

C18H28O2Rh2 (482.0199)


   

2-Naphthalenesulfonic acid, 6-hydroxy-5-[2-(2-methoxy-5-methyl-4- sulfophenyl)diazenyl]-, aluminum salt (1:1)

2-Naphthalenesulfonic acid, 6-hydroxy-5-[2-(2-methoxy-5-methyl-4- sulfophenyl)diazenyl]-, aluminum salt (1:1)

C18H19AlN2O8S2 (482.0398)


   

Lead(II) salicylate

Lead(II) salicylate

C14H10O6Pb (482.0244)


   

3-bromo-7,12-diphenylbenzo[k]fluoranthene

3-bromo-7,12-diphenylbenzo[k]fluoranthene

C32H19Br (482.067)


   

bis(3,4-dimethylphenyl)iodanium,hexafluorophosphate

bis(3,4-dimethylphenyl)iodanium,hexafluorophosphate

C16H18F6IP (482.0095)


   

1H,1H-2,5-BIS(TRIFLUOROMETHYL)-3,6-DIOXAPERFLUORONONANOL

1H,1H-2,5-BIS(TRIFLUOROMETHYL)-3,6-DIOXAPERFLUORONONANOL

C9H3F17O3 (481.9811)


   

4-[2-(4-carboxy-3-nitrophenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]-2-nitrobenzoic acid

4-[2-(4-carboxy-3-nitrophenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]-2-nitrobenzoic acid

C17H8F6N2O8 (482.0185)


   

cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl-4-methylbenzenesulphonate

cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl-4-methylbenzenesulphonate

C21H20Cl2N2O5S (482.047)


   

[3,3,4,4,5,5,6,6,7,8,8,8-dodecafluoro-7-(trifluoromethyl)octyl] 2-methylprop-2-enoate

[3,3,4,4,5,5,6,6,7,8,8,8-dodecafluoro-7-(trifluoromethyl)octyl] 2-methylprop-2-enoate

C13H9F15O2 (482.0363)


   

PD0325901

N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

C16H14F3IN2O4 (481.995)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C69145 - Mitogen-Activated Protein Kinase Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Mirdametinib (PD0325901) is an orally active, selective and non-ATP-competitive MEK inhibitor with an IC50 of 0.33 nM. Mirdametinib exhibits a Kiapp of 1 nM against activated MEK1 and MEK2. Mirdametinib suppresses the expression of p-ERK1/2 and induces apoptosis. Mirdametinib has anti-cancer activity for a broad spectrum of human tumor xenografts[1][2][3].

   

8-Carboxy-8-demethylriboflavin 5-phosphate

8-Carboxy-8-demethylriboflavin 5-phosphate

C17H15N4O11P-4 (482.0475)


   

4-O-sulfo-beta-D-galactopyranosyl-(1->4)-3,6-anhydro-2-O-sulfo-D-galactose

4-O-sulfo-beta-D-galactopyranosyl-(1->4)-3,6-anhydro-2-O-sulfo-D-galactose

C12H18O16S2-2 (482.0036)


   

2,6-dichloro-3-(glutathion-S-yl)-hydroquinone

2,6-dichloro-3-(glutathion-S-yl)-hydroquinone

C16H18Cl2N3O8S- (482.0192)


   

3,6-anhydro-2-O-sulfo-alpha-D-galactopyranosyl-(1->3)-4-O-sulfo-D-galactose

3,6-anhydro-2-O-sulfo-alpha-D-galactopyranosyl-(1->3)-4-O-sulfo-D-galactose

C12H18O16S2-2 (482.0036)


   
   

2-[(2,6-dichlorophenyl)sulfonylamino]-3-methylbutanoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester

2-[(2,6-dichlorophenyl)sulfonylamino]-3-methylbutanoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester

C21H20Cl2N2O5S (482.047)


   

4-(4-chlorophenyl)sulfonyl-5-(3,4-dihydro-1H-isoquinolin-2-yl)-2-ethylsulfonylthiazole

4-(4-chlorophenyl)sulfonyl-5-(3,4-dihydro-1H-isoquinolin-2-yl)-2-ethylsulfonylthiazole

C20H19ClN2O4S3 (482.0195)


   

2-Phenyl-5-thiophen-2-yl-3-pyrazolecarboxylic acid [2-(4-chloro-3-nitroanilino)-2-oxoethyl] ester

2-Phenyl-5-thiophen-2-yl-3-pyrazolecarboxylic acid [2-(4-chloro-3-nitroanilino)-2-oxoethyl] ester

C22H15ClN4O5S (482.0452)


   

2-Phenyl-5-thiophen-2-yl-3-pyrazolecarboxylic acid [2-(2-chloro-5-nitroanilino)-2-oxoethyl] ester

2-Phenyl-5-thiophen-2-yl-3-pyrazolecarboxylic acid [2-(2-chloro-5-nitroanilino)-2-oxoethyl] ester

C22H15ClN4O5S (482.0452)


   

2-(5,6-dibromo-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl)-N-(4-methylphenyl)propanamide

2-(5,6-dibromo-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl)-N-(4-methylphenyl)propanamide

C19H20Br2N2O3 (481.9841)


   

N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-5-(2-pyridinyl)-2-thiophenesulfonamide

N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-5-(2-pyridinyl)-2-thiophenesulfonamide

C18H12F6N2O3S2 (482.0194)


   

6-Bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(thiophen-2-ylthio)methyl]-3-indolecarboxylic acid ethyl ester

6-Bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(thiophen-2-ylthio)methyl]-3-indolecarboxylic acid ethyl ester

C20H23BrN2O3S2 (482.0333)


   

[2-[5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxyoxan-3-yl] hydrogen sulate

[2-[5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-4,5-dihydroxyoxan-3-yl] hydrogen sulate

C20H18O12S (482.0519)


   

THYMIDINE-5-triphosphATE

THYMIDINE-5-triphosphATE

C10H17N2O14P3 (481.9893)


A thymidine phosphate having a triphosphate group at the 5-position.

   

7,7'-dihydroxy-3-[(2-oxochromen-7-yl)oxy]-[8,8'-bichromene]-2,2'-dione

7,7'-dihydroxy-3-[(2-oxochromen-7-yl)oxy]-[8,8'-bichromene]-2,2'-dione

C27H14O9 (482.0638)


   

(10r,11r,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaene-8,17-dione

(10r,11r,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaene-8,17-dione

C20H18O14 (482.0697)


   

(10r,11s,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaene-8,17-dione

(10r,11s,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaene-8,17-dione

C20H18O14 (482.0697)


   

2,3-hexahydroxydiphenyl-D-glucose

NA

C20H18O14 (482.0697)


{"Ingredient_id": "HBIN004100","Ingredient_name": "2,3-hexahydroxydiphenyl-D-glucose","Alias": "NA","Ingredient_formula": "C20H18O14","Ingredient_Smile": "C1=C2C(=C(C(=C1O)O)O)C3=C(C(=C(C=C3C(=O)OC4C(C(C(OC4O)CO)O)OC2=O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42628","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2,3-o-(s)-hexahydroxydiphenoyl-d-gluco-pyranose

NA

C20H18O14 (482.0697)


{"Ingredient_id": "HBIN004147","Ingredient_name": "2,3-o-(s)-hexahydroxydiphenoyl-d-gluco-pyranose","Alias": "NA","Ingredient_formula": "C20H18O14","Ingredient_Smile": "C1=C2C(=C(C(=C1O)O)O)C3=C(C(=C(C=C3C(=O)OC4C(C(C(OC4O)CO)O)OC2=O)O)O)O","Ingredient_weight": "482.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15749","TCMID_id": "9501","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "14035453","DrugBank_id": "NA"}

   

(10s,11r,12r,13r,15r)-3,4,5,11,12,13,21,22,23-nonahydroxy-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(19),2,4,6,20,22-hexaene-8,18-dione

(10s,11r,12r,13r,15r)-3,4,5,11,12,13,21,22,23-nonahydroxy-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(19),2,4,6,20,22-hexaene-8,18-dione

C20H18O14 (482.0697)


   

(2r)-2,3-dihydroxypropoxy((2s)-3-{[(2r,3r,4s,5s)-5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-hydroxypropoxy)phosphinic acid

(2r)-2,3-dihydroxypropoxy((2s)-3-{[(2r,3r,4s,5s)-5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-hydroxypropoxy)phosphinic acid

C13H28AsO12P (482.0534)


   

3,4,5,11,12,13,21,22,23-nonahydroxy-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(19),2,4,6,20,22-hexaene-8,18-dione

3,4,5,11,12,13,21,22,23-nonahydroxy-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(19),2,4,6,20,22-hexaene-8,18-dione

C20H18O14 (482.0697)


   

4-chloro-5-[2-chloro-4-(2-chloro-6-methylphenoxy)-3,5,6-trimethylphenoxy]-3-methoxybenzene-1,2-diol

4-chloro-5-[2-chloro-4-(2-chloro-6-methylphenoxy)-3,5,6-trimethylphenoxy]-3-methoxybenzene-1,2-diol

C23H21Cl3O5 (482.0455)


   

7'-hydroxy-7-[(7-hydroxy-2-oxochromen-3-yl)oxy]-[6,8'-bichromene]-2,2'-dione

7'-hydroxy-7-[(7-hydroxy-2-oxochromen-3-yl)oxy]-[6,8'-bichromene]-2,2'-dione

C27H14O9 (482.0638)


   

5,7-dibromo-3a-(3,7-dimethylocta-2,6-dien-1-yl)-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-4-ol

5,7-dibromo-3a-(3,7-dimethylocta-2,6-dien-1-yl)-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-4-ol

C21H28Br2N2O (482.0568)


   

3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(22),2(7),3,5,18,20-hexaene-8,17-dione

3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(22),2(7),3,5,18,20-hexaene-8,17-dione

C20H18O14 (482.0697)


   

(1s,19r,21s,22r,23r)-6,7,8,11,12,13,21,22,23-nonahydroxy-2,17,20-trioxatetracyclo[17.3.1.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,6,8,10(15),11,13-hexaene-3,16-dione

(1s,19r,21s,22r,23r)-6,7,8,11,12,13,21,22,23-nonahydroxy-2,17,20-trioxatetracyclo[17.3.1.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,6,8,10(15),11,13-hexaene-3,16-dione

C20H18O14 (482.0697)


   

2,3-dihydroxypropoxy(3-({5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl}oxy)-2-hydroxypropoxy)phosphinic acid

2,3-dihydroxypropoxy(3-({5-[(dimethylarsoryl)methyl]-3,4-dihydroxyoxolan-2-yl}oxy)-2-hydroxypropoxy)phosphinic acid

C13H28AsO12P (482.0534)


   

7-hydroxy-7'-[(7-hydroxy-2-oxochromen-3-yl)oxy]-[6,8'-bichromene]-2,2'-dione

7-hydroxy-7'-[(7-hydroxy-2-oxochromen-3-yl)oxy]-[6,8'-bichromene]-2,2'-dione

C27H14O9 (482.0638)


   

(14s,15r,19r)-2,3,4,7,8,9,19-heptahydroxy-14-[(1r,2r)-1,2,3-trihydroxypropyl]-13,16-dioxatetracyclo[13.3.1.0⁵,¹⁸.0⁶,¹¹]nonadeca-1,3,5(18),6(11),7,9-hexaene-12,17-dione

(14s,15r,19r)-2,3,4,7,8,9,19-heptahydroxy-14-[(1r,2r)-1,2,3-trihydroxypropyl]-13,16-dioxatetracyclo[13.3.1.0⁵,¹⁸.0⁶,¹¹]nonadeca-1,3,5(18),6(11),7,9-hexaene-12,17-dione

C20H18O14 (482.0697)


   

2,3,4,7,8,9,19-heptahydroxy-14-(1,2,3-trihydroxypropyl)-13,16-dioxatetracyclo[13.3.1.0⁵,¹⁸.0⁶,¹¹]nonadeca-1,3,5(18),6(11),7,9-hexaene-12,17-dione

2,3,4,7,8,9,19-heptahydroxy-14-(1,2,3-trihydroxypropyl)-13,16-dioxatetracyclo[13.3.1.0⁵,¹⁸.0⁶,¹¹]nonadeca-1,3,5(18),6(11),7,9-hexaene-12,17-dione

C20H18O14 (482.0697)


   

6,7,8,11,12,13,21,22,23-nonahydroxy-2,17,20-trioxatetracyclo[17.3.1.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,6,8,10(15),11,13-hexaene-3,16-dione

6,7,8,11,12,13,21,22,23-nonahydroxy-2,17,20-trioxatetracyclo[17.3.1.0⁴,⁹.0¹⁰,¹⁵]tricosa-4,6,8,10(15),11,13-hexaene-3,16-dione

C20H18O14 (482.0697)


   

(3as,8as)-5,7-dibromo-3a-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-4-ol

(3as,8as)-5,7-dibromo-3a-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1-methyl-2h,3h,8h,8ah-pyrrolo[2,3-b]indol-4-ol

C21H28Br2N2O (482.0568)


   

(10r,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaene-8,17-dione

(10r,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-13-(hydroxymethyl)-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaene-8,17-dione

C20H18O14 (482.0697)


   

(2s,3s,4r,5s)-2-{[5,8-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}-4,5-dihydroxyoxan-3-yl sulfonate

(2s,3s,4r,5s)-2-{[5,8-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}-4,5-dihydroxyoxan-3-yl sulfonate

C20H18O12S (482.0519)